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Abstract 
Background: In the United States, female breast cancer was the leading cause of new cancer 
cases from 2011-2015. Since the Women’s Health and Cancer Act of 1998 (WHCRA), the 
federal government mandates employee and private health insurance providers to cover breast 
reconstruction if they cover mastectomies. Postmastectomy breast reconstruction (PBR) rates 
increased after the WHCRA, but these rates have remained relatively low throughout recent 
years. Objective: The objective of this study was to determine factors associated with women 
having PBR due to breast cancer in Nevada and the United States from 2008 to 2013. Methods: 
Using two HCUP database, NIS and SID databases, this study used complex multiple logistic 
regression and binary logistic regression to analyze the association between PBR and specific 
demographic, payer type, and hospital characteristics in the United States and Nevada. Weighted 
frequencies were calculated for the different breast reconstruction procedures and comorbidities 
that this study utilizes. Results: The results demonstrated that women who were younger, non-
African American, had private health insurance, were in the high-income status category, and 
received care at an urban teaching hospital had higher odds of having PBR than other women. In 
Nevada and the United States, surgeons performed tissue expander insertions more than any 
other breast reconstruction procedure. The same nine comorbidities were prevalent among 
women in the United States and Nevada. Conclusion: Disparities among age, payer types, 
racial/ethnic groups, and socioeconomic status in PBR still exist in the United States. Nevada 
should consider implementing breast reconstruction education policies to decrease these 
disparities and policy makers should ensure that federally mandated education is available in 
multiple languages, as well as, representative of all of cultures. 
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1 
Introduction 
Female breast cancer was the leading cause of new cancer cases from 2011-2015, with an 
incidence rate of 124.7 new cases per 100,000 women in the United States. Over the past decade, 
breast cancer rates have stayed relatively constant between 121 and 125 new breast cancer cases 
per 100,000 females (U.S. Cancer Statistics Working Group, 2018). There was a 36% decrease 
in breast cancer death rates in the United States from 1989-2012. This decrease could be related 
to better prevention screenings (mammography and MRIs) and advancements in treatment 
options (American Cancer Society, 2015). 
Mammectomies and mastectomies are the two primary surgical treatments for breast 
cancer. A mammectomy is a procedure that removes only the neoplasm (tumor) in the breast. It 
is considered a breast-conserving surgery and is also called a partial mastectomy, a lumpectomy, 
or a wide local excision (McGuire et al., 2009; American Cancer Society, 2015). A 
mammectomy followed by radiation has the same survival rates as a mastectomy for early-stage 
breast cancer. For this reason, mammectomy rates have increased in the past twenty years in the 
United States for all ages, races, and ethnicities (Hwang, Lichtensztajn, Gomez, Fowble, & 
Clarke, 2013). There are two main types of mastectomies, simple and radical. A radical 
mastectomy involves removal of the entire breast, areola, nipple, all levels of the axillary lymph 
nodes, and both pectoral muscles. Over the years, the radical mastectomy procedure has had 
modifications. The main difference is the preservation of pectoral muscles and level III axillary 
lymph nodes. Radical mastectomies are not common today; surgeons perform modified radical 
mastectomies instead. Another option is a simple mastectomy. This procedure removes breast 
tissue, areola, and the nipple. Mastectomies depend on the patients’ stage and type of cancer and 
can be performed on one (unilateral) or both breasts (bilateral) (McGuire et al., 2009; Willey & 
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Manasseh, 2011). Just like mammectomy rates, mastectomy rates have been increasing. 
Hospital-based bilateral mastectomies due to cancer have increased threefold from 10 
mastectomies to 29.7 mastectomies per 100,000 women between 2005 to 2013. In that same time 
range, inpatient mastectomy (all causes) rates doubled, while outpatient mastectomy (all causes) 
rates increased over fivefold (Steiner, Weiss, Barrett, Fingar, & Davis, 2016). The increased 
rates of these two surgical treatments have contributed to increased breast reconstruction rate as 
well (McGuire et al., 2009).   
The Women’s Health and Cancer Rights Act of 1998 (WHCRA) mandated employee and 
private health insurance providers to cover breast reconstruction in policies if they cover 
mastectomies. Mandates included covering the various stages of breast reconstruction, 
reconstruction of the uninflected breast for symmetry, and WHCRA is not limited to 
mastectomies due to cancer (Wong-Pan, 2012). State legislation began to pass laws that allowed 
Medicaid and Medicare to cover breast reconstruction. From 1998-2008, postmastectomy breast 
reconstruction (PBR) rates increased from 20.8% to 37.8% and advancements in breast 
reconstruction surgery contributes to increasing rates (Shippee, Kozhimannil, Rowan, & Virnig, 
2014). Legislation has helped make reconstruction accessible, as well as, a vital part of breast 
cancer treatment for women (Liaw et al., 2013; Butler, Familusi, Serletti, & Fox, 2017).  
 A patient can either have postmastectomy breast reconstruction (PBR), which involves 
having reconstruction at the same time as a mastectomy or delay breast reconstruction (DBR) 
until another time. The decision to have PBR or to postpone it can be due to various reasons. 
Either patient’s personal preference or receiving radiation may be reasons for them to wait to 
have breast reconstruction. Radiation can increase the chances of complications, like flap 
necrosis, implant exposure, and problems with tissue expanders (McCue, Miglior, & 
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Cunningham, 2010.) Despite these reasons, PBR has gained popularity over the years. From 
2005-2012, PBR rates have increased by 50% (Kwok, Goodwin, Ying, & Agarwal, 2014).  
 Surgeons perform several different types of breast reconstruction today, but this study 
will only analyze certain procedures. Breast implants and tissue expanders have been used the 
longest for breast reconstruction and are the simplest reconstruction procedures. If there is 
enough tissue to cover the implant after a mastectomy, surgeons will insert a breast implant into 
a pocket they created under the pectoralis major muscle. If there is not enough tissue after a 
mastectomy, tissue expanders are placed into the pocket instead. After the surgery, expanders are 
filled with a saline solution over months (up to six months) until the desired size is achieved 
(McCue et al., 2010).   
Autologous flaps are another breast reconstruction procedure. Surgeons use the patient’s 
skin and tissue from another place on their body to reconstruct the breast(s). These flaps will 
result in a more natural breast than implants. The latissimus dorsi (LD) flap is a procedure where 
surgeons use part of the LD muscle, fat, tissue, and skin to reconstruct the breast(s). Implants, as 
well as, tissue expanders can be used with this flap procedure, and blood vessels remain attached 
to the original blood supply. (Boehmler & Butler, 2010). Another autologous flap is the 
transverse rectus abdominis myocutaneous (TRAM) flap. Surgeons use the rectus abdominis 
muscle, along with abdominal fat, skin, and blood vessels to reconstruct the breast(s). There are 
two versions of the TRAM flap this study will analyze: pedicle and free. TRAM pedicle is 
similar to the LD flap because the blood vessels stay connected to the original blood supply, 
while the TRAM free flap involves microsurgery that attaches the blood vessels to a new blood 
supply closer to the breast (Weiss, 2010; Liaw et al., 2013). The deep inferior epigastric artery 
perforator (DIEP) flap is a free flap procedure that evolved from the TRAM flap. It conserves the 
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rectus abdominal muscles and only uses abdominal fat, tissue, and skin to reconstruct the 
breast(s). Just like the TRAM flap, the rectus abdominis is dissected to reach the blood vessels 
needed for the flap (Lipa, 2010). Another procedure that conserves the rectus abdominal muscles 
is the superficial inferior epigastric artery (SIEA) flap. This flap is similar to the DIEP flap, but 
the blood vessels needed for the flap are superficial to the rectus abdominal muscles, meaning 
those muscles are left undisturbed (Spiegel & Eldor, 2010). The gluteal artery perforator (GAP) 
flap is the last breast reconstruction procedure analyzed in this study. This procedure uses gluteal 
blood vessels instead of abdominal blood vessels and does not use any muscle in the flap. Two 
different arteries can be used, the inferior gluteal artery and the superior gluteal artery. The usage 
of either one depends on preferred scar position, distribution of fat, and if sizable blood vessels 
can be found. This procedure is usually used as an alternate when other autologous flaps will not 
work for the patient (Cheng & Huang, 2010). 
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Background and Significance 
Mastectomies are an essential part of breast cancer treatment, but this procedure can have 
a negative impact on a woman’s social, psychological, and sexual function (Veronesi et al., 
2011; Platt, Baxter, & Zhong, 2011). A literature review reports that out of thirteen papers, most 
of them claimed that up to 50% of women reflected a lower body image than before their 
mastectomy (McGaughey, 2006). Al-Ghazal and coauthors (2000) concluded that 63% of their 
patients who had PBR did not lose their sense of sexual attractiveness, which they believe 
corresponds with sexual function. The researchers also suggest that patients who had PBR 
showed a lower level of distress than patients that had DBR (Al-Ghazal, Sully, Fallowfield, & 
Blamey, 2000). Breast reconstruction has shown to decrease the severity of negative impacts 
caused by a mastectomy, so it is essential for physicians to discuss breast reconstruction options 
with all patients (Morrow, Scott, Menck, Mustoe, & Winchester, 2001; Reuben, Manwaring, & 
Neumayer, 2009; Veronesi et al., 2009; McGuire et al., 2009). 
 PBR was an unpopular choice for breast cancer treatment historically. Initially, surgeons 
questioned whether PBR would affect detection of reoccurring breast cancer (Morrow et al., 
2001; McGuire et al., 2009). Noone and colleagues (1993) reported that when patients had a 
reoccurrence of breast cancer, breast reconstruction did not affect detection and PBR did not 
increase reoccurrence rates (Noone et al., 1994). With the advancements in breast reconstruction 
mentioned already, these procedures do not interfere with detecting breast cancer reoccurrence 
(Atisha et al., 2008; Barnsley, Sigurdson, & Kirkland, 2008; Morrow et al., 2001; Reuben et al., 
2009). 
Three years after the WHCRA, PBR was recommended as an early-stage breast cancer 
treatment by the Commission on Cancer of the American College of Surgeons. After this 
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happened, these rates rose (Platt et al., 2011). Yang and colleagues (2012) found that before 
policy changes, PBR rates were 18.5% in Pennsylvania, these rates nearly doubled between 2001 
and 2004 to 32.7% (Yang et al., 2013). Even though PBR rates increased after policy changes, 
they remain relatively constant today (Platt et al., 2011; Reuben et al., 2009; Yang et al., 2013). 
Furthermore, several population-based studies found that between 2003 and 2007 only 25% to 
35% of women have PBR in the United States (Morrow et al., 2014; Kruper et al., 2011; 
Alderman et al., 2009; Reuben et al. 2009). Researchers speculate several factors influence the 
breast reconstruction decision-making process, but they know little about the women having 
PBR (Morrow et al., 2001; Rueben et al., 2009).  
Age is speculated to have a critical role in this decision-making process. It is believed 
that older women are not having breast reconstruction as often as younger women because they 
have more comorbidities that could affect the surgery (Platt et al., 2011). Despite this belief, 
Reuben and colleagues (2009) found that age was a factor for PBR after controlling for 
comorbidities (Rueben et al., 2009). The reasons why older women do not have PBR as often as 
younger women are still unknown. It could be due to personal preference or not being informed 
about their options by their physicians (Lipa, Youssef, Kuerer, Robb, & Chang, 2003).  
Race and ethnicity are factors that can potentially influence a woman’s decision to have 
PBR. A study that assessed the impact of the WHCRA on PBR rates found that the WHCRA did 
not eliminate the racial/ethnic disparities in PBR, even though that was the intent. Minority 
women were still less likely than white women to have PBR (Alderman, Wei, & Birkmeyer, 
2006). A lack of breast reconstruction education for minorities and cultural differences in the 
value of women’s breasts may be associated with these racial/ethnic disparities (Yang et al., 
2013). 
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Socioeconomic status (SES) and payer type may potentially influence PBR rates. Barriers 
could exist for women with lower SES that don’t exist for women with higher SES regarding 
breast reconstruction, including lower education levels, not having a consultation with a 
reconstruction surgeon, seeing a physician that is not educated on breast reconstruction, and not 
having access to appropriate care (Morrow et al., 2001; Kruper et al., 2011). The influence from 
payer type, SES, and race combined may have more of an impact on the breast reconstruction 
decision-making process than if they were analyzed individually. More research is needed to 
understand the effect these factors have on breast reconstruction (Butler et al., 2018).  
The location and type of the hospital a woman goes to can impact the breast 
reconstruction decision-making process. Urban hospitals have the ability for larger plastic 
surgery departments that can perform more types of breast reconstruction than rural hospitals 
can, which could be an advantage for patients (Kruper et al., 2011; Reuben et al., 2009). Along 
with urban hospitals, a few studies found that National Cancer Institute (NCI)-Designated 
Cancer Centers were 40% more likely to perform PBR than other hospital types (Morrow et al., 
2001; McGuire et al., 2009). Research shows that both NCI-Designated Cancer Centers and 
teaching hospitals perform PBR more than nonteaching hospitals (Kruper et al., 2011; Reuben et 
al., 2009; Platt et al., 2011).  
Significance and Objective 
In a literature search for published studies on PBR, there were no studies to our 
knowledge specific to Nevada. State-specific data are needed to identify the populations having 
PBR in each state. Furthermore, Reuben et al. (2009) concluded that the published national data 
on PBR is outdated. The objective of this study is to determine factors associated with women 
having PBR due to breast cancer in Nevada and the United States from 2008 to 2013.   
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Research Questions 
1. Which demographic variables are associated with PBR due to breast cancer in Nevada 
and the United States? 
▪ H0= There are no demographic variables associated with PBR due to breast cancer 
in Nevada and the United States. 
▪ HA= There are demographic variables associated with PBR due to breast cancer in 
Nevada and the United States. 
2. Does the location and the teaching status of the hospital affect whether a woman has PBR 
due to breast cancer in the United States? 
▪ H0= There is no difference in the location and teaching status of hospitals with 
women who had PBR compared to women who did not have breast reconstruction 
after a mastectomy due to breast cancer in the United States. 
▪ HA= There is a difference in the location and teaching status of hospitals with 
women who had PBR compared to women who did not have breast reconstruction 
after a mastectomy due to breast cancer in the United States. 
3. Does payer type affect whether a woman has PBR due to breast cancer in the United 
States and Nevada? 
▪ H0= There is no difference in payer types with women who had PBR compared to 
women who did not have breast reconstruction after a mastectomy due to breast 
cancer in the United States and Nevada. 
▪ HA= There is a difference in payer types with women who had PBR compared to 
women who did not have breast reconstruction after a mastectomy due to breast 
cancer in the United States and Nevada. 
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4. Are there certain types of breast reconstruction performed more frequently during PBR 
due to breast cancer in Nevada and the United States? 
▪ H0= There is no difference in the types of breast reconstruction performed during 
PBR due to breast cancer in Nevada and the United States.  
▪ HA= There is a difference in the types of breast reconstruction performed during 
PBR due to breast cancer in Nevada and the United States. 
5. Are there comorbidities that are more prevalent with PBR due to breast cancer in Nevada 
and the United States? 
▪ H0= There are no differences in the prevalence of comorbidities between those 
with and without having breast reconstruction after a mastectomy due to breast 
cancer in Nevada and the United States. 
▪ HA= There are differences in the prevalence of comorbidities between those with 
and without having breast reconstruction after a mastectomy due to breast cancer 
in Nevada and the United States. 
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Methodology 
Databases  
 This study is a secondary analysis utilizing two Healthcare Cost and Utilization Project 
(HCUP) databases. The HCUP databases are a collection of several healthcare databases 
supported by the Agency for Healthcare Research and Quality (AHRQ). In the United States, this 
database contains a vast amount of longitudinal data on hospital care, including “all-payer” data. 
HCUP was initiated in 1988 and was designed to improve hospital care by providing a potent 
source of national, state, and “all-payer” information for organizations to use (Healthcare Cost 
and Utilization Project [HCUP], 2018[a]). It is important to note HCUP uses discharge record as 
the unit, not individual patients (HCUP, 2018[c]).  
The National (Nationwide) Inpatient Sample (NIS) is an HCUP database that contains 
data on inpatient care in the United States. The NIS database represents approximately 97% of 
US hospital discharges (only short-term, non-Federal hospitals) regardless of the payer type, 
resulting in an available sample of several million discharge records per year (HCUP, 2018[b]). 
In 2012, the NIS database changed from the Nationwide Inpatient Sample to the National 
Inpatient Sample. The name change was due to improvements made to the database, the most 
crucial being sample design. The new NIS database receives discharge records from all HCUP 
hospitals rather than from a sample of hospitals. All changes were made to reduce sampling error 
and more precise estimates (HCUP, 2018[c]).  
The State Inpatient Databases (SID) contain all inpatient records (clinical and nonclinical 
information) for states that choose to participate. It differs from the NIS database because the 
NIS database is a sample of discharge records in the United States, while the SID databases 
include discharge records from states that participate. The SID databases are essential for 
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obtaining estimates for individual states since the NIS database was not designed for such 
analyses (HCUP, 2018[c]).  
Study Population 
The NIS and the SID databases were used to identify discharge records of female breast 
cancer patients between the ages of 18 and 90 years who had a mastectomy between 2008 and 
2013 in both Nevada and the United States. Participant’s breast cancer diagnosis and mastectomy 
type were determined based on the International Classification of Diseases, ninth revision (ICD-
9) (Table 1 & Table 2). 
 
 
Table 1. ICD-9 Diagnosis Codes for Breast Cancer 
Code  Procedure  
174 Malignant neoplasm nipple 
174.1 Malignant neoplasm breast-central  
174.2 Malignant neoplasm breast up-inner 
174.3 Malignant neoplasm breast low-inner 
174.4 Malignant neoplasm breast up-outer 
174.5 Malignant neoplasm breast low-outer 
174.6 Malignant neoplasm breast-axillary 
174.8 Malignant neoplasm breast NEC (Malignant neoplasm of other specified sites of female breast) 
174.9 Malignant Neoplasm Breast NOS (Malignant Neoplasm of breast (female) unspecified) 
233 Carcinoma in situ of breast 
238.3 Neoplasm of uncertain behavior of breast 
239.3 Neoplasm of unspecified nature of breast 
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Table 2. ICD-9 Procedure Codes for Mastectomy 
Code  Procedure  
85.33 Unilateral subcutaneous mammectomy with synchronous implant 
85.34 Other unilateral subcutaneous mammectomy 
85.35 Bilateral subcutaneous mammectomy with synchronous implant 
85.36 Other bilateral subcutaneous mammectomy 
85.4 Mastectomy 
85.41 Unilateral simple mastectomy 
85.42 Bilateral simple mastectomy 
85.43 Unilateral extended simple mastectomy 
85.44 Bilateral extended simple mastectomy 
85.45 Unilateral radical mastectomy 
85.46 Bilateral radical mastectomy 
85.47 Unilateral extended radical mastectomy 
85.48 Bilateral extended radical mastectomy 
 
 
Variables  
The dependent variable derived from the data represented breast reconstruction status 
(RECON). RECON was determined by eleven different ICD-9 breast reconstruction procedure 
codes (Table 3). It is a dichotomous variable with 1= having breast reconstruction and 0= not 
having breast reconstruction. In this study, twenty-nine comorbidity variables were used to create 
a comorbidity indicator variable that was used as a covariate in the multiple logistic regression 
models (SUMCMBS; Table 4). SUMCMBS is the sum of the twenty-nine variables, and it is 
continuous.  
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Table 3. ICD-9 Procedures Codes that Create RECON 
Code  Procedure 
85.53 Unilateral breast implant 
85.54 Bilateral breast implant 
85.95 Insertion of breast tissue expander 
85.71 Latissimus dorsi myocutaneous flap 
85.72 Transverse rectus abdominis myocutaneous flap, pedicled 
85.73 Transverse rectus abdominis myocutaneous flap, free 
85.74 Deep inferior epigastric artery perforator (DIEP) flap, free 
85.75 Superficial inferior epigastric artery (SIEA) flap, free 
85.76 Gluteal artery perforator (GAP) flap, free 
85.7 Total Reconstruction of Breast 
85.79 Other total reconstruction of breast 
 
 
Table 4. List of Comorbidities that Creates SUMCMBS 
Variable Name Description  
CM_AIDS Acquired immune deficiency syndrome 
CM_ALCOHOL Alcohol abuse 
CM_ANEMDEF Deficiency anemias 
CM_ARTH Rheumatoid arthritis/collagen vascular diseases 
CM_BLDLOSS Chronic blood loss anemia 
CM_CHF Congestive heart failure 
CM_CHRNLUNG Chronic pulmonary disease 
CM_COAG Coagulopathy 
CM_DEPRESS Depression 
CM_DM Diabetes 
CM_DMCX Diabetes with chronic complications 
CM_DRUG Drug abuse 
CM_HTN_C Hypertension (combine uncomplicated and complicated) 
CM_HYPOTHY Hypothyroidism 
CM_LIVER Liver disease 
CM_LYMPH Lymphoma 
CM_LYTES Fluid and electrolyte disorders 
CM_METS Metastatic cancer 
CM_NEURO Other neurological disorders 
CM_OBESE Obesity 
CM_PARA Paralysis 
CM_PERIVASC Peripheral vascular disorders 
CM_PSYCH Psychoses 
CM_PULMCIRC Pulmonary circulation disorders 
CM_RENLFAIL Renal failure 
CM_TUMOR Solid tumor without metastasis 
CM_ULCER Peptic ulcer disease excluding bleeding 
CM_VALVE Valvular disease 
CM_WGHTLOSS Weight loss 
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Several purportedly important predictors were utilized for modeling. Four out the five 
independent variables were categorical in this study. The HCUP databases were obtained 
initially with categorized variables. In the SID database, age (AGE1) was separated into three 
groups; 18-40 years old, 41-64 years old, and 65-90 years old, while in the NIS data models, age 
(AGE1) was grouped by decades except for two groups; 18-29 years old and 80-90 years old. 
Payer type (PAYERTYPE) was categorized into six different categories for both databases; 1= 
Other 2= No charge 3= Medicare 4= Medicaid 5= Self-pay 6= Private insurance. In the NIS 
database, the private insurance category included private HMOs and PPOs, commercial carriers, 
and Blue Cross. The other category was defined as government programs including Worker’s 
Compensation, CHAMPUS (TRICARE) and CHAMPVA, and Title V. CHAMPVA and 
TRICARE are two military healthcare programs that serve active duty members and retired 
members, their families, and veterans (Benefits.gov, n.d). Title V is a federal grant program 
focused on providing a wide variety of health care to mothers and children with barriers to 
quality health care (Health Resources & Services Administration [HRSA], 2019). In the SID 
database, Worker’s Compensation was included in the private health insurance category until 
2012 where it was moved to the other category (HCUP, 2018[d]). Race (RACE1) was grouped 
into six categories for the NIS database; 1= Other 2= Native American 3= Asian or Pacific 
Islander 4= Hispanic 5= White, 6= African American. For the SID database though, race 
(RACE1) was categorized into two groups; white and nonwhite. Median household income for 
patient’s zip code (ZIPINC_QRTL) was grouped into quartiles based on median income by year 
(Table 5); 1= 0-25th percentile (low-income) 2= 26th-50th percentile (low/middle-income) 3= 51st-
75th percentile (high/middle-income) 4= 76th-100th percentile (high-income). The variable for 
hospital location and teaching status (HOSP_LOCTEACH) had three categories; 1= Rural 2= 
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Urban nonteaching 3= Urban teaching. This variable combines hospital location and teaching 
status into one variable. The individual variables for location (HOSP_LOCATION) and teaching 
status (HOSP_TEACH) were discontinued in 2011 and thus were not used in this study. The SID 
database, however, does not include variables to analyze hospital location or hospital teaching 
status, and therefore the state-based models will not contain HOSP_LOCTEACH (HCUP, 
2018[d]). 
 
 
Table 5. Quartile Ranges for ZIPINC_QRTL by Year 
Year Quartile 1 Quartile 2 Quartile 3 Quartile 4 
2008 1 - 38,999 39,000 - 48,999 49,000 - 63,999 64,000+ 
2009 1 - 39,999 40,000 - 49,999 50,000 - 65,999 66,000+ 
2010 1 - 40,999 41,000 - 50,999 51,000 - 66,999 67,000+ 
2011 1 - 38,999 39,000 - 47,999 48,000 - 63,999 64,000+ 
2012 1 - 38,999 39,000 - 47,999 48,000 - 62,999 63,000+ 
2013 1 - 37,999 38,000 - 47,999 48,000 - 63,999 64,000+ 
 
 
Data Preparation  
 The NIS and SID databases includes many diagnosis and procedure codes, making these 
databases extensive and complex (HCUP, 2018[a]). A solution to this complexity was to remove 
all discharge records that did not include any of the twelve breast cancer codes listed in Table 1 
and any of the thirteen mastectomy codes in Table 2 from the two databases. The removal of 
these discharge records resulted in the final dataset that was utilized for analyses. In addition, 
discharge records for women who were not between the ages of 18 and 90 years old were 
removed from both databases as well.  
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When reviewing these datasets, the discharge records showed some women having 
multiple breast reconstruction procedures during the same surgery. This study was concerned 
with whether a woman did or did not have breast reconstruction and not with the total quantity of 
breast reconstruction procedures they had. The RECON variable was created to accommodate 
this. There were fifteen procedure variables (PR1-15) in the NIS database and twenty-five in the 
SID database. These procedure variables were recoded into RECON1-15 for the NIS database 
and RECON1-25 for the SID database. RECON1-25 categorized the ICD-9 breast reconstruction 
codes (Table 3) from 1 through 11, removing procedure codes that were not the breast 
reconstruction codes in the study. The sum of these variables was computed into SUMRECON. 
SUMRECON was then recoded into RECON, which defined reconstruction as a “1” and no 
reconstruction as a “0”.  
This study controlled for whether a woman had comorbidities or not, but a variable had to 
be created from the two databases to define it. The sum of the twenty-nine variables listed in 
Table 4 was computed into one variable called SUMCMBS, which was a continuous, count 
variable. The NIS and SID databases had the same twenty-nine comorbidity variables.  
Indicator variables were created for several of the independent variables to ensure that the 
reference group would be the highest value in all the independent variables. All new category 
descriptions were defined in the ‘Variables’ section of the methods. The first indicator variable 
was AGE1. AGE1 was created by recoding AGE, a continuous variable, into seven categories. 
The SID database sample size was too small to use seven categories, so it was separated into 
three categories instead. In the NIS database, the ‘40-49 years old’ category is the reference 
group and the ’41-64 years old’ category is the reference group for the SID database. The second 
indicator variable was RACE1. The variable RACE was recoded from 1= White 2= African 
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American 3= Hispanic 4= Asian or Pacific Islander 5= Native American, and 6= Other to have 
the ‘African American’ category be the reference group for the NIS database. Originally, the 
‘White’ category was the reference group for the NIS database, but the ‘African American’ 
category reference group yielded interesting results. The variable RACE was recoded into 
RACE1 differently for the SID database to accommodate for sample size, and the ‘nonwhite’ 
category was the reference group. The last indicator variable is PAYERTYPE. PAY1 was 
recoded from 1= Medicare 2= Medicaid 3= Private insurance 4= Self-pay 5=No charge 6= Other 
to set the ‘Private insurance’ category as the reference group. All data preparation was completed 
using IBM SPSS Statistics 25 Syntax Editor.   
Statistical Analyses  
Discharge records from the NIS database were obtained using a design-based complex 
sample which incorporates complex weighting to produce accurate national estimates. The 
HCUP database provides a weighting variable called discharge weight (DISWT) (HCUP, 2015). 
DISWT was applied to the NIS database by creating a complex sample plan. All analyses and 
frequencies performed for the NIS database used this complex plan as the dataset. The SID data, 
on the other hand, did not require a weight variable and therefore, did not need to have a 
complex sample plan. 
The NIS data were analyzed using IBM SPSS Statistics 25 Complex Samples, while the 
SID data were analyzed using IBM SPSS Statistics 25 Software. The statistical analysis for this 
study was based on the methods used by Reuben and coauthors (2009) in a study that analyzed 
predictors of PBR using NIS data from 1999 to 2003 (Reuben et al., 2009). The significance 
level was set to a p < 0.05 with a confidence level of 95% for all regression models.  
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 For research questions 1 through 3, complex samples logistic regression models were 
produced for the individual independent variables for each year for the NIS data (30 models in 
total) and binary logistic regression models were created for the independent variables for the 
SID data (four models in total). CMBS was not used as a covariate in the individual logistic 
regression models. These models were created to analyze the association between each 
independent variable and the dependent variable, RECON. After these models were produced, 
independent variables were added into a model together. The NIS data produced six complex 
samples multiple logistic regression models that represented each year of the database. These 
models included two interaction variables. The first interaction was RACE1 and 
HOS_LOCTEACH and the other was RACE1 and ZIPINC_QRTL. Six multiple binary logistic 
regression models were created for the SID data representing each year occurring in the 
database. Since HOSP_LOCTEACH was not a variable available in the SID database, these 
models only included RACE1 and ZIPINC_QRTL as an interaction variable.  
Unfortunately, due to the small sample size of PBR, models of the SID database could 
not be separated by individual years and therefore had to be created for the entire dataset. It 
should be noted that a small sample size can inflate the odds ratios and increase the associated 
confidence intervals. Variables were kept in the model even if they were not significant. There 
are known relationships between the independent variables, chosen for this study, and breast 
reconstruction outcomes. The interactions are important to keep in the models because there are 
also known relationships between race and SES, as well as, race and hospital characteristics with 
breast reconstruction outcomes (Reuben et al., 2009; Platt et al., 2011; Shippee et al., 2014; 
Kruper et al., 2011). Lastly, year trends were not calculated in this study. The change in the NIS 
database sample design in 2012 made it difficult to produce trend analyses across all the years.  
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Research question 4 and 5 were not analyzed by creating logistic regression models. 
Frequencies were calculated for each year for the eleven categories in RECON1-15 for the NIS 
data. The frequencies of the eleven categories in RECON1-25 were calculated for the entire SID 
database. It is worth noting that women could have multiple breast reconstruction procedures 
performed in the same surgery, meaning these frequencies represent how many procedures were 
performed each year, not how many women got these breast reconstruction procedures. To 
determine if specific comorbidities were prevalent in the study populations at least 10% of the 
study population would need to have the comorbidity in question. Frequencies were calculated 
for the twenty-nine comorbidity variables based on breast reconstruction status for each 
database.  
Ethical Considerations  
 Any identifying information was removed by AHRQ before the two HCUP databases 
were received. AHRQ requires researchers to complete the HCUP Data Use Agreement Training 
before using any HCUP database. The author’s completion certificate can be found in Appendix 
B. A research proposal that included this study was submitted for review to the UNLV School of 
Medicine Internal Review Board (IRB). This board decided that the research proposal was 
exempt from IRB review (Appendix C).  
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Results 
The NIS Database: United States Results 
In the United States, a total of 1,216,214 women between the ages of 18 to 90 years old 
had a mastectomy due to breast cancer between 2008 and 2013. Out of that population, 179,923 
women had PBR. The PBR rates for each year were 11.2%, 14.3%, 15.4%, 15.8%, 16.3%, and 
15.9%, respectively. The maximum number of comorbidities women had in this population were 
thirteen. Women who had PBR experienced one or no comorbidities 74.8% of the time, while the 
women who did not have breast reconstruction had one or no comorbidities 29.9% of the time. 
The median ages were 51.7 years old for women who had PBR and 63.2 years old for women 
who did not have breast reconstruction. This population was predominately white, went to an 
urban teaching hospital, and had private insurance, regardless of reconstruction status. The high-
income quartile represented 42.1% of the PBR population, while 13.5% of the PBR population 
was in the low-income quartile. For the no reconstruction population, the low-income quartile 
had the highest percentage of women in it with 27.1%, while the high-income quartile had the 
lowest percentage with 23.4% of the women. The results for the number of comorbidities 
experienced in the United States is in Table 6. Demographic frequencies for the overall United 
States model can be found in Table 7, while demographic frequencies for individual years are in 
Appendix A, Table 8. 
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Table 6. Number of Comorbidities Experienced in the United States 
Number of 
comorbidities 
Reconstruction n(%) 
No reconstruction 
n(%) 
Total n(%) 
0 79,368(44.1) 94,031(9.1) 173,399(14.3) 
1 55,272(30.7) 195,117(18.8) 250,389(20.6) 
2 28,471(15.8) 226,364(21.8) 254,835(21.0) 
3 11,218(6.2) 201,065(19.4) 212,283(17.5) 
4 4,000(2.2) 145,587(14) 149,587(12.3) 
5 1,189(0.7) 87,785(8.5) 88,974(7.3) 
6 302(0.2) 47,803(4.6) 48,104(4.0) 
7 78(0) 23,400(2.3) 23,478(1.9) 
8 15(0) 9,790(0.9) 9,805(0.8) 
9 10(0) 3,695(0.4) 3,705(0.3) 
10 0 1,221(0.1) 1,221(0.1) 
11 0 321(0) 321(0) 
12 0 87(0) 87(0) 
13 0 26(0) 26(0) 
 
 
Table 7. Demographic Frequencies for the Overall United States 
Variable Reconstruction n(%) No reconstruction n(%) 
Age      
Median age ± SD 51.7±10.5 63.2±14.0 
18-29 years old 2,392(1.3) 5,746(0.60) 
30-39 years old 18,156(10.1) 42,255(4.1) 
40-49 years old 58,919(32.7) 139,712(13.5) 
50-59 years old 57,414(31.9) 226,192(21.8) 
60-69 years old 34,417(19.1) 262,849(25.4) 
70-79 years old 7,980(4.4) 210,266(20.3) 
80-90 years old 645(0.4) 149,272(14.4) 
Race      
White 124,224(75.4) 642,415(69.4) 
African American 16,265(9.9) 153,042(16.5) 
Hispanic 12,259(7.4) 75,812(8.2) 
Asian/Pacific 5,629(3.4) 25,446(2.7) 
Native American 554(0.3) 4,202(0.5) 
Other 5,756(3.5) 25,036(2.7) 
Payer type     
Private Insurance 137,918(76.7) 349,298(33.8) 
Self-pay 1,689(0.9) 19,869(1.9) 
Medicaid 12,672(7.1) 129,635(12.5) 
Medicare 22,877(12.7) 509,425(49.2) 
No charge 347(0.2) 4,017(0.4) 
Other 4,238(2.4) 22,327(2.2) 
Household income status      
Low income 23,845(13.5) 274,519(27.1) 
Low/middle income 32,058(18.2) 254,329(25.1) 
High/middle income 46,224(26.2) 247,601(24.4) 
High income 74,306(42.1) 237,167(23.4) 
Hospital location/teaching 
status  
    
Rural 3,594(2.0) 118,033(11.5) 
Urban nonteaching 56,624(31.7) 403,819(39.2) 
Urban teaching 118,428(66.3) 507,118(49.3) 
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The independent variables, not controlling for comorbidities, were significant in the 
individual complex samples logistic regression models. However, the interaction between race 
(RACE1) and SES (ZIPINC_QRTL) was not significant for all the years in the complex samples 
multiple logistic regression models. P-values for this interaction are as follows from 2008 to 
2013: 0.20, <0.001, 0.16, 0.31, 0.09, and 0.5, respectively. This interaction was not significant in 
the overall United States model. The interaction between race (RACE1) and hospital 
characteristics (HOSP_LOCTEACH) was not significant in 2011 (p-value=0.66) and 2013 (p-
value=0.5) in the complex samples multiple logistic regression models, but it was significant in 
the overall United States model. In 2012, ZIPINC_QRTL was not significant (p-value=0.13) in 
that complex samples multiple logistic regression model. However, the six categories in 
PAYERTYPE remained significant over the years in this study and in the overall United States 
model. Results for the individual independent variable models are in Appendix A, Table 9, while 
results for individual years for the complex samples multiple logistic regression models can be 
found in Appendix A, Table 10. 
In the overall United States complex samples multiple logistic regression model, women 
between the ages of 40 and 49 years old had higher odds of having PBR than any other age 
group. The 18-29 years old group was not significant during any of the years and remained not 
significant in the overall United States model (OR=1.01, CI[0.89-1.15]). African American 
women had lower odds of having PBR than women from any other race category in the overall 
United States model. The Asian and Pacific Islander and Native American categories were not 
significant in any of the models, except in 2009, with odds ratios of 0.55 (CI[0.37,0.82]) and 
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0.27 (CI[0.10,0.74]). Women with private insurance had higher odds of having PBR than women 
with any other payer type in the overall United States model. Women in the self-pay category 
had the lowest odds of having PBR out of the six different payer type categories compared to 
private insurance. Specifically, in 2011, the self-pay category had an odds ratio of 7.54 
(CI[5.08,11.2]). Women in the high-income quartile had higher odds of having PBR than women 
in any other income quartile. Women who had a mastectomy at a rural hospital had lower odds 
of having PBR than women who had a mastectomy at an urban teaching hospital in the overall 
United States model (OR=9, CI[5.50,14.7]). Similarly, women who had a mastectomy at an 
urban nonteaching hospital had 1.42 lower odds of having PBR than women who had a 
mastectomy at an urban teaching hospital (CI[1.29,1.56]). All results for the individual year 
complex samples multiple logistic regression models are in Appendix A, Table 10, while results 
for the overall United States model is in Table 11.  
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Table 11: Complex Samples Multiple Logistic Regression for the Overall United States 
Variable (reference group) Odds ratio  95% C.I P-value 
Age (40-49 years old)     <0.001 
18-29 years old 1.01 0.89-1.15   
30-39 years old 1.06 1.01-1.12   
50-59 years old 1.33 1.28-1.38   
60-69 years old  1.75 1.68-1.82   
70-79 years old 3.91 3.65-4.19   
80-90 years old 31.1 25.8-37.6   
Race (African American)     <0.001 
White 0.64 0.58-0.71   
Hispanic 0.76 0.66-0.88   
Asian/Pacific 1.07 0.93-1.25   
Native American 0.85 0.50-1.44   
Other 0.68 0.57-0.80   
Payer type (private insurance)     <0.001 
Self-pay 4.35 3.82-4.96   
Medicaid 3.02 2.87-3.17   
Medicare 1.97 1.88-2.06   
No charge 5.01 3.83-6.55   
Other 1.65 1.51-1.80   
Household income status (high 
income) 
    <0.001 
Low income 1.85 1.65-2.07   
Low/middle income 1.48 1.31-1.69   
High/middle income 1.18 1.04-1.34   
Hospital location/teaching status 
(urban/teaching) 
    <0.001 
Rural 9.00 5.50-14.7   
Urban nonteaching 1.42 1.29-1.56   
 
 
Out of the eleven breast reconstruction procedures (Table 3), the insertion of breast tissue 
expanders was performed 67.7% of the time in the overall United States model. The DIEP free 
flap procedure was performed the most out of the autologous flap procedures (6.6%), followed 
by the latissimus dorsi myocutaneous flap (5.7%). The SIEA free flap procedure was seldom 
used in this study (0.3%). Unilateral and bilateral breast implants were inserted equally. 
Frequencies for the breast reconstruction procedures for the overall United States and individual 
years can be found in Table 12. 
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Table 12. Breast Reconstruction Procedure Frequencies for the United States (individual 
years & total) and Nevada (total) 
Year  2008 2009 2010 2011 2012 2013 U.S. Total Nevada Total 
Reconstruction type 
n n n n n n n(%) n(%) 
Unilateral breast 
implant 
1,887 1,780 2,021 2,302 2,065 1,385 11,440(4.4) 80(7.6) 
Bilateral breast implant 1,772 1,552 1,850 1,869 2,260 1,855 11,158(4.3) 128(12.1) 
Insertion of breast 
tissue expander 
24,189 26,880 30,850 33,068 31,198 30,940 177,125(67.7) 645(61.0) 
Latissimus dorsi 
myocutaneous flap 
638 2,483 2,476 3,124 3,015 3,070 14,806(5.7) 143(13.5) 
TRAM flap, pedicled 657 2,399 2,123 2,107 1,665 1,225 10,176(3.9) 25(2.4) 
TRAM flap, free 667 2,044 2,046 1,533 2,240 1,945 10,475(4.0) 10(0.95) 
DIEP flap, free 473 3,168 2,264 3,912 3,640 3,745 17,202(6.6) 5(0.47) 
SIEA flap, free 51 242 152 93 170 160 868(0.3) 1(0.09) 
GAP flap, free 5 60 30 37 50 60 242(0.09) 0(0) 
Total reconstruction of 
breast 108 698 541 397 455 555 2,754(1.1) 7(0.66) 
Other total 
reconstruction of breast 
110 647 890 1,054 1,306 1,455 5,462(2.1) 14(1.3) 
 
 
There were twenty-nine comorbidities analyzed in this study (Table 4). Nine of these 
comorbidities were prevalent in the overall United States. Hypertension [reconstruction (R): 
25.4%; no reconstruction (NR): 49.3%], hypothyroidism (R: 10.3%; NR: 13.4%) and metastatic 
cancer (R: 10.2%; NR: 29.1%) were prevalent regardless of reconstruction status. Deficiency 
anemias (19%), fluid and electrolyte disorders (23.7%), chronic pulmonary disease (14.9%), 
depression (11.7%), diabetes (18.3%), and solid tumors without metastasis (34.8%) were 
prevalent only in the population that did not have reconstruction. Results from the twenty-nine 
comorbidities can be found in Table 13. 
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Table 13. Comorbidity Frequencies for the United States and Nevada 
  U.S.   Nevada   
Comorbidity type 
Reconstruction 
n(%) 
No reconstruction 
n(%) 
Reconstruction 
n(%) 
No reconstruction 
n(%) 
Acquired immune deficiency syndrome 47(0) 776(0.1) 0 4(0.1) 
Alcohol abuse 632(0.4) 9,671(0.9) 5(0.7) 60(0.9) 
Deficiency anemias 7068(3.9) 197,211(19) 21(2.9) 1602(24.0) 
Rheumatoid arthritis/collagen vascular 
diseases 
2,414(1.3) 23,904(2.3) 5(0.7) 99(1.5) 
Chronic blood loss anemia 503(0.3) 9,325(0.9) 1(0.1) 62(0.9) 
Congestive heart failure 625(0.3) 65,645(6.3) 2(0.3) 354 (5.3) 
Chronic pulmonary disease 15,215(8.5) 154,566(14.9) 58(8.1) 1096(16.4) 
Coagulopathy 890(0.5) 58,956(5.7) 1(0.1) 560(8.4) 
Depression 15,991(8.9) 121,072(11.7) 49(6.9) 666(10) 
Diabetes 11,075(6.2) 189,681(18.3) 40(5.6) 1101(16.5) 
Diabetes with chronic complications 497(0.3) 26,745(2.6) 0 97(1.5) 
Drug abuse 481(0.3) 9,828(0.9) 3(0.4) 78(1.2) 
Hypertension (combine 
uncomplicated and complicated) 
45,673(25.4) 510,952(49.3) 193(27) 3007(45.1) 
Hypothyroidism 18,525(10.3) 139,273(13.4) 74(10.4) 965(14.5) 
Liver disease 770(0.4) 19,935(1.9) 2(0.3) 131(2) 
Lymphoma 362(0.2) 5,898(0.6) 2(0.3) 36(0.5) 
Fluid and electrolyte disorders 3,250(1.8) 245,148(23.7) 7(1.0) 1765(26.5) 
Metastatic cancer 18,291(10.2) 301,654(29.1) 54(7.6) 2012(30.2) 
Other neurological disorders 2,608(1.4) 52,173(5) 12(1.7) 354(5.3) 
Obesity 12,166(6.8) 94,040(9.1) 56(7.8) 560(8.4) 
Paralysis 188(0.1) 16,480(1.6) 1(0.1) 95(1.4) 
Peripheral vascular disorders 598(0.3) 27,349(2.6) 1(0.1) 114(1.7) 
 Psychoses 1,952(1.1) 35,001(3.4) 4(0.6) 158(2.4) 
Pulmonary circulation disorders 389(0.2) 22,966(2.2) 1(0.1) 164(2.5) 
Renal failure 745(0.4) 64,052(6.2) 4(0.6) 344(5.2) 
Solid tumor without metastasis 4,940(2.7) 360,575(34.8) 18(2.5) 2254(33.8) 
Peptic ulcer disease excluding bleeding 14(0.0) 261(0.0) 0 5(0.1) 
Valvular disease 4,127(2.3) 32,243(3.1) 11(1.5) 154(2.3) 
Weight loss 344(0.2) 56,239(5.4) 0 427(6.4) 
*Bolded comorbidities are prevalent in the United States and Nevada 
 
The SID Database: Nevada Results 
In Nevada, there were 7,382 women between the ages of 18 and 90 years old who had a 
mastectomy due to breast cancer between 2008 to 2013. Out of these women, 714 had PBR. The 
PBR rate was 9.7%. Women had a maximum of twelve comorbidities. Seventy-six percent of 
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women who had PBR had one or no comorbidities, while 29.3% of women who did not have 
breast reconstruction had one or no comorbidities. The median ages were 52.6 years old for 
women who had PBR and 62.2 years old for women who did not have breast reconstruction. Out 
of the PBR population, 67.2% were between the ages of 41 and 64 years old, were predominately 
white, had private insurance, and represented the high/middle income or the high-income 
quartiles. The no reconstruction population was predominantly insured by Medicare (45.3%) 
more than by private insurance (39.5%). The number of comorbidities experienced in Nevada is 
in Table 14, while demographic frequencies for this database can be found in Table 15. 
 
Table 14. The Number of Comorbidities Experienced in Nevada 
Number of comorbidities 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Total n(%) 
0 345(48.3) 687(10.3) 1,032(14.0) 
1 198(27.7) 1,265(19.0) 1,463(19.8) 
2 106(14.8) 1,353(20.3) 1,459(19.8) 
3 48(6.7) 1,250(18.7) 1,298(17.6) 
4 15(2.1) 936(14.0) 951(12.9) 
5 1(0.1) 612(9.2) 613(8.3) 
6 1(0.1) 313(4.7) 314(4.3) 
7 0 155(2.3) 155(2.1) 
8 0 52(0.8) 52(0.7) 
9 0 35(0.5) 35(0.5) 
10 0 7(0.1) 7(0.1) 
11 0 1(0) 1(0) 
12 0 2(0) 2(0) 
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Table 15. Demographic Frequencies for Nevada 
Variable  
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Age     
18-40 years old  106(14.8) 351(5.3) 
41-64 years old  480(67.2) 3360(50.4) 
65-90 years old  128(18.0) 2957(44.3) 
Mean ± SD age 52.56 ±11.21 62.15 ±13.23 
Race     
White 55(77) 4679(70.2) 
African American 41(5.7) 796(11.9) 
Hispanic 51(7.1) 453(6.8) 
Asian or Pacific Islander 39(5.5) 398(6.0) 
Native American 2(0.3) 33(0.5) 
Other 20(2.8) 207(3.1) 
Payer type     
Private Insurance  545(76.3) 2632(39.5) 
Self-pay 7(1.0) 220(3.3) 
Medicaid 24(3.4) 576(8.6) 
Medicare 122(17.1) 3023(45.3) 
No Charge 0(0.0) 14(0.2) 
Other 15(2.1) 132(2.9) 
Household income status     
Low income 67(9.4) 1058(15.9) 
Low/middle income 133(18.6) 1508(22.6) 
High/middle income 251(35.2) 2088(31.3) 
High income 241(33.8) 1776(26.6) 
 
 
The four independent variables were significant in the individual logistic regression 
models for Nevada, while ZIPINC_QRTL and the interaction between race (RACE1) and SES 
(ZIPINC_INC) was not significant in the multiple logistic model. Results from the individual 
logistic models can be found in Appendix A, Table 16 and results for the multiple logistic model 
can be found in Table 17.  
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Table 17. Multiple Logistic Regression Model for Nevada 
Variable (reference group) Odds ratio  95% C.I P-Value 
Age (41-64 years old)     0.001 
18-40 years old 0.73 0.55-0.95   
65-90 years old 1.60 1.16-2.20   
Race (nonwhite)     0.02 
White 0.65 0.45-0.93   
Payer type (private insurance)     <0.001 
Self-pay 5.00 2.30-10.9   
Medicaid 3.62 2.32-5.65   
Medicare 1.90 1.37-2.62   
Other 1.85 1.05-3.25   
Household income status (high 
income) 
    0.58 
Low income 1.30 0.74-2.29   
Low/middle income 1.80 0.77-2.10   
High/middle income 0.97 0.62-1.51   
Interaction of race and 
household income 
(nonwhite/high income) 
    0.99 
White*low income 0.96 0.49-1.88   
White*low/middle income 0.92 0.52-1.64   
White*high/middle income 1.01 0.61-1.67   
 
 
In the multiple logistic regression model, women between the ages of 18 and 40 years 
older had 27% higher odds of having PBR compared to women between the ages of 41 and 64 
years old. When looking at the women in the 65 to 90 years old category, though, the odds were 
1.6 times lower for having PBR compared to women in the 41 to 64 years old category. White 
women had 35% higher odds of having breast reconstruction than nonwhite women. There were 
similarities with the overall United States when it came to payer type. Self-pay had the lowest 
odds ratio of having PBR compared to private insurance out of the payer type categories 
(OR=5.00, CI[2.30,10.9]). The other payer type category had 1.85 (CI[1.05,3.25]) times lower 
odds of having PBR compared to the private insurance category. Discharge records did not show 
‘no charge’ as a payer type for women who had PBR in Nevada (Table 14). Therefore, an odds 
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ratio could not be calculated. Other results from the multiple logistic regression model for 
Nevada can be found in Table 17.  
 Inserting tissue expanders was performed the most out of the eleven breast reconstruction 
procedures (61%). Out of the autologous flaps, the latissimus dorsi myocutaneous flap procedure 
was used at least five times as often as any other autologous flap (13.5%). The GAP free flap 
procedure was the only autologous flap procedure not performed in Nevada. Bilateral breast 
implants (12.1%) were inserted more frequently than unilateral breast implants (7.6%). Breast 
reconstruction procedure frequencies can be found in Table 12.  
 The same nine comorbidities were prevalent in Nevada that were prevalent in the United 
States. Hypertension (R:27%; NR:45.1%) and hyperthyroidism (R:10.4%; NR:14.5%) were 
prevalent in both the PBR and no reconstruction population, while deficiency anemias (24%), 
chronic pulmonary disease (16.4%), depression (10%), diabetes (16.5%), fluid and electrolyte 
disorders (26.5%), metastatic cancer (30.2%), and solid tumors without metastasis (33.8%) were 
prevalent in only the no reconstruction population. Frequencies for the twenty-nine comorbidities 
can be found in Table 13. 
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Discussion 
Hospital Location and Teaching Status 
 In this study, 66.3% of women in the United States had PBR at an urban teaching 
hospital, while only 2% of that population had PBR at a rural hospital. Out the women who did 
not have PBR, 11.5% of the women had a mastectomy at a rural hospital, while 49.3% of these 
women had a mastectomy at an urban teaching hospital (Table 7). Women who had a 
mastectomy at a rural or an urban nonteaching hospital had lower odds of having PBR compared 
to women who had a mastectomy at an urban teaching hospital (Table 11). These results are 
consistent with other researchers’ findings (Reuben et al., 2009; Kruper et al., 2011; Platt et al., 
2011).  
The plastic surgeon’s location could partially explain why PBR is performed more at 
urban teaching hospitals compared to rural hospitals. Plastic surgeons are not distributed equally 
between urban and rural hospital settings. As of 2015, there were 53 plastic surgeons in Nevada 
with 42 of them residing in Southern Nevada, 11 in Northwestern Nevada and zero plastic 
surgeons in Northeastern Nevada (Griswold, Gunawan, & Packham, 2018). It is known that 
teaching hospitals and hospitals in urban areas can support surgical teams who perform difficult 
breast reconstruction procedures better than hospitals in rural areas (Kruper et al., 2011; Berlin, 
Wilkins, & Alderman, 2018). One study analyzed the relationship between plastic surgeon 
density in small geographic areas and breast reconstruction rates in 10 states. The researchers 
found that approximately half of the variation in breast reconstruction rates (delayed and 
immediate) between urban and rural areas could be explained by the density of plastic surgeons 
per people during 2010 (Bauder et al., 2017).  
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Additionally, PBR rates can be negatively impacted by how difficult it is to coordinate 
the schedules of plastic and general surgeons to perform PBR at rural hospitals (Rubin, Chavez, 
Alderman, & Pusic, 2013; Berlin, 2018; Bauder et al., 2017). In the United States, more plastic 
surgeons who perform PBR are needed to increase the access of these procedures in rural areas 
and, in general, to fill the void of the large number of retiring plastic surgeons (Noone, Goldwyn, 
McGrath, Spear, & Evans, 2007). Several studies suggested that allowing general surgeons to 
perform breast reconstruction procedures, instead of only mastectomies, would help increase 
access to PBR. This concept has worked internationally in other medical fields, such as 
otolaryngology (Berlin et al., 2018; Bauder et al., 2017; Winters, Pou, & Friedlander, 2011). 
Limited access to PBR in rural areas has the potential to negatively affect the 274,622 Nevadans 
living in rural Nevada (Rural Health Information Hub [RHIhub], 2019). This study could not 
assess the relationship between rural hospitals in Nevada and PBR rates due to the unavailability 
of a hospital location variable or a similar variable in the SID database.    
In addition to the reasons stated above, living in specific regions of the United States can 
positively impact PBR rates. Reuben et al. (2009) concluded, between 1999 and 2003, women 
who received care in the South had increased odds of having PBR than women who received 
care in the Midwest, Northeast, or the West. The authors mentioned that PBR was first 
established in hospitals in the South, which increased the number of plastic surgeons available 
there (Reuben et al., 2009). An older study found different results though. Women in the South 
and the Midwest were less likely to have PBR compared to the Mountain and Pacific regions 
during 1994-1995 (Morrow et al., 2001). Hospital region was not analyzed as an independent 
factor for PBR because this study was concerned with the United States, as a whole, and Nevada.  
Delayed and Outpatient Breast Reconstruction  
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Between 2008 and 2013, PBR rates in the United States ranged from 11.2%-15.9%, while 
the PBR rate in Nevada was 9.7% in this study. United States PBR rates have decreased roughly 
10% since 2003 (25.3%) when using data obtained by the NIS database (Reuben et al., 2009). 
The cause of decreasing PBR rates in the NIS database is not entirely understood. 
 Increasing outpatient breast cancer treatment surgeries could provide an explanation, but 
there is conflicting information in the literature. According to a study that analyzed data from 28 
states via SID databases and State Ambulatory Surgery and Services Databases (SASD), 
outpatient mastectomies accounted for 43% of all mastectomy surgeries in 2012 (Steiner et al., 
2016). In contrast, a study that used Californian data found that outpatient mastectomy rates 
(20.4% to 23.9%) did not increase as much as inpatient mastectomy rates (29.2% to 41.6%) 
during 2006-2009. Moreover, the authors concluded that while outpatient PBR rates increased 
from 7.7 to 10.3%, inpatient PBR was more popular, and the rates increased from 29.2% to 
41.6% (Kruper et al., 2011). Bauder et al. (2017) found that in their study population only 15.5% 
of the women received a mastectomy in an outpatient setting and their overall (immediate and 
delayed) breast reconstruction rate was 44.7% (Bauder et al., 2017). Another study that used SID 
databases and SASD found that inpatient PBR rates remained constant during 2009-2014 (7.4 to 
7.3 per 100,000 women), while outpatient PBR rates increased by 155% (1.1 to 2.8 per 100,000 
women). Even though there was an increase in outpatient PBR rates during this study, PBR was 
performed in an inpatient setting more (Miller, Steiner, Barrett, Fingar, & Elixhauser, 2017). 
Like outpatient breast cancer treatment surgeries, DBR rates have increased over the 
years. One study found a 10.1% increase in DBR from 2009 to 2014 in 22 states. Specifically, in 
2014, 71% of the overall breast reconstruction rate was from DBR procedures (Miller et al., 
2017). Those results are different from a study that analyzed data from the Mastectomy 
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Reconstruction Outcomes Consortium (MROC) from 2012 to 2015. This study resulted in only 
7.7% of the study population choosing to have DBR. The authors found that women who needed 
radiation therapy, in conjunction with a mastectomy, had lower complication rates if they waited 
to have breast reconstruction until after their treatment was completed (Yoon et al., 2018). DBR 
is more popular in older women who have several comorbidities, and in women who live in rural 
areas. Even though DBR has been shown to have lower complication rates for specific 
procedures, like autologous flaps, plastic surgeons still prefer to perform PBR when possible 
(Bauder et al., 2017; Yoon et al., 2018). 
Breast Reconstruction Procedures  
The most popular breast reconstruction procedure was the insertion of breast tissue 
expanders in the United States and Nevada (Table 12). During breast reconstruction, surgeons 
may use tissue expanders, in combination, with other procedures, explaining the large number of 
tissue expander insertion in this study (McCue et al., 2010; Boehmler & Butler, 2010). When 
examining the use of breast implants, Nevadan surgeons inserted breast implants more often 
(19.6%) than surgeons in the United States did (8.7%). U.S. surgeons performed autologous flap 
procedures 20.59% of the time, while 17.4% of the time, Nevadan surgeons performed 
autologous flap procedures. 
Although this study only analyzed the frequencies of breast reconstruction procedures, 
there are known relationships between different subpopulations of women and specific breast 
reconstruction procedures. Women 35 years old and younger, and, women between the ages of 
65 and 74 years old preferred having breast implants over any other procedures (Alderman, 
McMahon, & Wilkins, 2003; Butler et al., 2016). African American women prefer having 
autologous flap procedures more than having breast implants (Rubin et al., 2013). Lastly, women 
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who had DBR were more likely to have an autologous flap procedure than any other 
reconstruction options (Yoon et al., 2018). 
Comorbidities 
 The same nine comorbidities were prevalent in the United States and Nevada in this 
study. On average, women who did not have breast reconstruction had more comorbidities than 
women who had PBR. This finding is consistent with other results about comorbidities in the 
literature. Several studies concluded that women with multiple medical conditions were less 
likely to have breast reconstruction than other women, or at least have more post-surgical 
complications (Yoon et al., 2018; Kruper et al., 2013; Veronesi et al., 2011). Butler et al. (2016) 
found that moderately obese women (30-34.9 kg/m2) had 1.46 higher odds (p-value= <0.001) of 
having post-surgical complications than women who were not obese (<30 kg/m2). The 
complications reported in this study were minor, like wound infection and breast implant 
failures. Though this study stated that morbidly obese women were more likely to have major 
complications than other women, it was determined that age and race were not independent 
predictors of post-surgical complications. Other comorbidities, such as cardiovascular disease 
and smoking, increased the odds of having complications after surgery (Butler et al., 2016). 
Lastly, physicians are less likely to discuss breast reconstruction options with women who have 
several comorbidities due to the increased risk of additional surgery (Veronesi et al., 2011).  
Age 
 The median age of women having PBR has not changed for the United States since 2003 
(Reuben et al., 2009). Median ages for women having PBR in Nevada and the United States 
were similar (Table 7 & Table 15). When age was analyzed in the individual logistic regression 
model, the gap between older and younger women having PBR was larger than the gap in the 
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multiple logistic regression model for both the United States and Nevada (Table 9; Table 11; 
Table 16; Table 17). There are several possible explanations for this gap increase, one could be 
that women who did not have PBR had more comorbidities than younger women in this study. 
Even when comorbidities were considered, older women do not have PBR as often as younger 
women.  This finding is consistent with the known relationship between age and PBR mentioned 
in other studies (Reuben et al., 2009, Butler et al., 2016; Alderman et al., 2003; Morrow et al., 
2001; Kruper et al., 2011; Veronesi et al., 2011).  
Payer Type, Race, and Socioeconomic Status 
This study found that nonwhite women had 35% lower odds of having PBR than white 
women in Nevada (Table 17), while African American women had lower odds of having PBR 
compared to women of other races in the United States (Table 11). These results are similar to 
other studies (Yang et al., 2013; Kwok et al., 2015). Several studies have shown that Asian 
women are one-third as likely as white women to have PBR (McGuire et al., 2009; Kruper et al., 
2011; Kwok et al., 2015). Another study found that Middle Eastern and Hispanic women the 
same odds for having PBR compared to white women, but African American and Asian women 
did not (Tseng et al., 2004). Interestingly, Reuben et al. (2009) concluded that race was only a 
significant predictor of PBR when hospital characteristics were controlled for (Reuben et al., 
2009) The interaction between race and hospital location/teaching status was significant in the 
multiple logistic regression model for the overall United States, but not for all the individual 
years.  
Researchers agree that African American women are disproportionately less likely to 
have PBR than white women (Alderman et al., 2009; Kruper et al., 2011). African American 
women are diagnosed with early-stage breast cancer less than other women (Rubin et al., 2013). 
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Later-stage cancer diagnoses can contribute to their lower PBR rates since mastectomies are 
recommended for early-stage breast cancer treatment (American Cancer Society, 2015). It should 
be mentioned that Morrow et al. (2005) concluded that African American women continued to 
have lower breast reconstruction rates after controlling for several factors, including the stage of 
breast cancer (Morrow et al., 2005). These authors provide evidence that other factors impact the 
low PBR rates in African American women. Alderman et al. (2009) found that African American 
women were less likely to have a consultation with a plastic surgeon than other women 
(Alderman et al., 2009). In addition, it has been reported that oncologists have shorter visits and 
have less discussion about their illness with African American patients (Mahmoundi, Lu, Metz, 
Momoh, & Chung, 2018). In one study, African American women agreed that they had less 
discussion, than desired, with their physician about the breast reconstruction options and they felt 
that their physician discouraged them from having PBR (Alderman et al., 2009). These results 
could partially be due to physician bias (Alderman et al., 2003) or from other reasons due to the 
patient’s health. Furthermore, medical distrust continues to affect the African American 
population from historical experiments that were unethical. (Rubin et al., 2013; Mahmoundi et 
al., 2018; Butler, Familusi, Serletti, & Fox, 2018). 
Nevada has a diverse population, with more than half of the population identifying as a 
different race than white. As of 2017, 31.1% of Nevadans speak a different language than 
English at home (U.S Census Bureau, 2017). Language barriers are contributing to lower PBR 
rates in women of color. Berlin et al. (2018) discussed that women who primarily speak Spanish 
seldom have PBR compared with other minority women (Berlin et al.,2018). Moreover, a study 
found that only 37% of medical graduates speak another language besides English (Mahmoundi 
et al., 2018). The absence of effective communication between a woman and her doctor could 
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negatively impact her decision on breast reconstruction, if she doesn’t fully understand her 
options (Yang et al., 2013; Shippee et al., 2014). Overall, minorities feel that they receive less 
counseling on breast reconstruction options and desire more information than provided 
(Alderman et al., 2009).   
SES has a tremendous impact on PBR rates (Mahmoundi et al., 2018). In this study, 
household income status was only significant in the United States while women with high-
income had higher odds of having PBR than the other income categories. The interaction 
between race and SES, however, was not significant in the multiple logistic regression models 
for the overall United States and Nevada. It is known that low-income women are less likely to 
have PBR than other women (Shippee et al., 2014). A few reasons these lower rates, include the 
amount of time they would have to take off from work, lack of insurance or inadequate insurance 
coverage, and less access to hospitals that can accommodate PBR procedures (Kruper et al., 
2011; Yang et al., 2013; Alderman et al., 2003).  
Other studies use payer type information as an indicator for SES since race disparities can 
be enhanced by unequal access to payer type (Kruper et al., 2011; Shippee et al., 2014). Women 
of color who had public insurance coverage were less likely to have PBR than white women with 
the same coverage (Rubin et al., 2013; Tseng et al., 2004; Shippee et al., 2014; Butler et al., 
2018). Payer type was an independent predictor of PBR in this study; the results were consistent 
with other studies. There was a disparity between the categories of payer type and private health 
insurance. Reimbursement differences among payer types are one contributing factor to 
racial/ethnic disparities. Private insurance has higher reimbursement rates for PBR and has lower 
out of pocket expenses for patients than other payer types. Therefore, plastic surgeons limit how 
many patients they have on public health insurance due to the lower reimbursement rates 
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(Bauder et al., 2017; Shippee et al., 2014; Kruper et al., 2011). Financial concerns and lack of 
private health insurance may be a factor in why women of color have lower rates of plastic 
surgeon consultations (Alderman et al., 2009). As demonstrated, racial/ethnic disparities of PBR 
have influences from various independent predictors, making it difficult to understand and 
address thoroughly. 
Physician-Patient Discussions and Patient Preferences  
 According to the literature, two factors have considerable influence on women’s breast 
reconstruction decision, discussions with physicians and the woman’s personal preference. 
Greenberg et al. (2008) concluded that the primary predictor for a woman to have PBR was a 
documented discussion on the various options between the woman and her physician in their 
study (Greenberg et al., 2008; Mahmoundi et al., 2017). As mentioned in the previous section, 
this discussion does not happen for every woman. Physicians’ knowledge about breast PBR 
options directly affects these discussions. A study based in Wisconsin reported that 40% of the 
general surgeons surveyed did not refer all their patients for breast reconstruction (Stacey et al., 
2008). Some of the reasons for not referring breast reconstruction to patients included concerns 
about cancer reoccurrence and patient’s age. A patient’s age alone should not deter physicians 
from discussing breast reconstruction options with patients (Reuben et al., 2009; Greenberg et 
al., 2008). Also, in the background section of this study, it was discussed that breast 
reconstruction does not hinder detecting cancer reoccurrences. Wanzel et al. (2002) found that 
90% of the plastic surgeons surveyed believed that not all women who were qualified for breast 
reconstruction were being referred to them because of a lack of physician knowledge on this 
topic. In addition, the authors confirmed that lack of correct knowledge is a common reason why 
women do not have breast reconstruction (Wanzel, Brown, Anastakis, & Regehr, 2002). Not all 
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studies believe this statement though. Some studies found that women who had high knowledge 
of breast reconstruction options still did not have breast reconstruction (Rubin et al., 2013; 
Morrow et al., 2005).   
 Patient preferences are significant contributing factors in the decision-making process on 
PBR. These preferences can be more influential than a physician’s advice or opinion (Morrow et 
al., 2005). One subpopulation where this statement may not be true is with older women. It is 
found that physicians opinion of breast reconstruction may impact an older woman’s decision 
more than it would their younger counterpart (Morrow et al., 2001). A reason could be that older 
women are more passive about breast reconstruction decisions and give their physician’s advice 
more power than younger women would (Alderman et al. 2003; Veronsi et al., 2011). On the 
other hand, older women may be passive about not learning more breast reconstruction because 
they don’t want to have additional surgery, which is a personal preference (Alderman et al., 
2003).  
Policy  
 The WHCRA did not reduce the racial/ethnic disparities associated with PBR (Rubin et 
al., 2013; Shippee et al., 2014; Kruper et al., 2011; Yang et al., 2013). In fact, researchers 
suggest that the WHCRA caused these disparities to widen even more (Mahmoundi et al., 2017). 
The reason is that the WHCRA did not introduce any regulations that controlled the differences 
between private and public insurance reimbursement rates (Butler et al., 2018; Rubin et al., 
2013). The disparities that form when payer types have different reimbursement rates for 
procedures has been discussed, but the group that is usually most impacted are minority women 
causing the disparity to grow (Shippee et al., 2014).  
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Since the WHCRA, several pieces of legislation have been introduced to try and decrease 
the racial/ethnic disparities in healthcare and increase knowledge of breast reconstruction 
options. The first piece of legislation is the Patient Protection and Affordable Care Act of 2010 
(ACA). The ACA is a healthcare reform law that provides subsidies to lower the cost of health 
insurance, which in turn, increases the access to healthcare. It mandated that all individuals need 
to have health insurance and insurance companies cannot deny access to people with preexisting 
conditions or people with a history of cancer care (Davis, Abrams, & Kristof, 2011). The ACA 
was enacted on March 23rd, 2010, and it took until January 1st, 2014 for most of the healthcare 
changes to happen (eHealth, 2018). One provision of the ACA was a Medicaid expansion 
program. States were allowed to choose whether or not they wanted to participate in it. This 
expansion would allow individuals to qualify for Medicaid if their income was under 138% of 
the federal poverty level. As of 2017, 31 states and Washington D.C choose to participate in the 
Medicaid expansion. In 2014, Nevada agreed to the Medicaid expansion (McGinley & 
Goldstein, 2017). In this study, there was an increase in Medicaid and Medicare coverage when 
comparing 2008 to 2013 for both Nevada and the United States (Table 18). Research shows that 
the ACA did reduce the overall racial/ethnic disparity in healthcare access (Chen, Vargas-
Bustamanate, Mortensen, & Oretga, 2016; Davis et al., 2011; Shippee et al., 2014).  
 
 
Table 18. Percent of Women Covered by Insurance in 2008 and 2013 for United States and 
Nevada 
Year Private Insurance Medicaid Medicare Other 
United States      
2008 42.2% 9.9% 43.2% 2.6% 
2013 37.8% 12.5% 45.5% 2.1% 
Nevada      
2008 45.9% 6.8% 39.9% 4.3% 
2013 36.7% 9.4% 47.1% 2.4% 
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The next piece of legislation is the New York Public Health (NY PBH) Law 2803-O 
(2011). This law was enacted on January 1st, 2011. It mandates that general hospitals must 
provide specific information to every patient having breast cancer treatment surgery. They must 
offer inpatient care after the surgery to every patient, as well as, provide information on the 
breast reconstruction options to every patient. This information needs to include; advantages and 
disadvantages of breast reconstruction procedures, how to access breast reconstruction care if 
that hospital does not offer it and how to acquire breast reconstruction after other treatments are 
finished, and the commissioner may require additional information as well. All information must 
be provided in written form, so that patients can refer to it later (NY PBH 2803-O, 2011). 
Mahmoundi et al. (2017) analyzed the effect of this law on breast reconstruction in New York 
during 2008-2011. The study resulted in three main findings; this law did not increase the overall 
PBR rate, it did not decrease the disparity between African American women and white women, 
but this law did decrease the disparity between Hispanic and white women, as well as, reducing 
the disparity between white women and other minorities (Mahmoundi et al., 2017).  
 The last piece of legislation that was introduced after the WHCRA to increase knowledge 
of breast reconstruction options is the Breast Cancer Patient Education Act of 2015. Two bills 
were introduced in the 114th U.S. legislative session, Senate Bill 1192 (2015) and House of 
Representative Bill 2540. Both these bills aimed to amend the Public Service Act to require the 
Department of Health and Human Services to plan and implement a breast reconstruction 
education campaign targeted towards women of color breast cancer patients (S.1192, 2015; 
H.R.2540, 2015). On December 18th, 2015, Congress enacted the Breast Cancer Patient 
Education Act (American Society of Plastic Surgeons, 2015). Overall, there is a national and 
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state level effort to implement policies that will decrease the racial/ethnic disparities in 
healthcare and increase knowledge of breast reconstruction options. 
Limitations   
 There were several limitations of this study. In secondary analyses, researchers do not 
decide what information is collected nor do they collect the data themselves. The NIS and SID 
databases use discharge records from various hospitals. It is possible that errors could have 
occurred when recording patient information, diagnosis and procedure codes, and hospital 
information. With discharge records in HCUP databases, it is difficult to determine if the same 
patient had multiple discharge records since they are not linked to patients. In addition, there was 
specific hospital characteristic information collected in the NIS database that was not available in 
the SID database. Due to this lack of information, this study was not able to determine the 
relationship between hospital location and teaching status and PBR rates in Nevada. 
  Another limitation of this study was the use of inpatient discharge records. In this study, 
the PBR rates produced are representative of PBR surgeries performed in an inpatient setting, but 
not of all the PBR surgeries in the United States and Nevada. Since trends show an increase in 
outpatient breast cancer treatment surgeries, this is a significant limitation. Also, the use of these 
discharge records didn’t allow this study to determine DBR rates for the United States and 
Nevada. The discharge records used only account for past and current procedures, meaning it 
cannot be determined if patients had DBR in the future.  
Future Public Health Policy and Research Recommendations 
 This study illustrates the continuation of disparities among age, payer types, 
race/ethnicities, and SES in PBR seen in previous years in the United States. The implementation 
of several policies has occurred in the last twenty years to try and decrease these disparities. 
 
 
44 
Further analysis of how effective policy efforts are on increasing minorities’ breast 
reconstruction rates at a state level is needed. Evidence has been provided by Mahmoundi et al. 
(2017) that shows the impact mandated education for breast cancer patients had on racial/ethnic 
disparities of PBR in New York (Mahmoundi et al., 2017). In addition to research, policy makers 
should ensure that federally mandated education is available in multiple languages, as well as, 
representative of all of cultures. Lastly, the American Society of Plastic Surgeons and policy 
makers should develop programs that will increase access to breast reconstruction in rural areas.  
  Multiple studies, including this one, have provided evidence to show that quantitative 
research alone cannot explain the differences in the breast reconstruction decision-making 
process among women. Discussions about breast reconstruction options and patient preferences 
are two factors that influence this decision-making process. More qualitative and mixed-methods 
research on these factors are needed to explain the variation in PBR rates among women in the 
United States and Nevada. Furthermore, additional research on outpatient breast reconstruction 
procedures and DBR is needed to gain a better understanding of the overall breast reconstruction 
rates in the United States and Nevada. 
 To the author’s knowledge, no published studies have analyzed state-specific data on 
PBR in Nevada. This study provided information on the variation that occurs among women who 
have PBR and who do not. The data used in this study was not the most recent data available. 
Additional research with more recent data on PBR is needed to understand the disparities of PBR 
in Nevada better.  
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Conclusion 
 The purpose of this study was to determine factors that are associated with women 
choosing whether or not to have PBR in the United States with more recent data. Additionally, 
this study aimed to provide insight into the specific groups of women who do or do not choose to 
have PBR in Nevada. Women who are younger, white, have private insurance, and seek care at 
an urban teaching hospital continue to be more likely to have PBR than other women. Despite 
the efforts of the WHCRA, disparities among age, payer types, racial/ethnic groups, and 
socioeconomic statuses in PBR still exist in the United States and Nevada. Research discussed in 
this study provides evidence that the breast reconstruction decision-making process is complex 
and relies heavily on patient’s knowledge of breast reconstruction options, patient-physician 
based discussions, and patient preferences. Nevada should use New York as an example and 
implement policies that mandate education on breast reconstruction options for all patients 
receiving breast cancer treatment surgery. In addition, plastic surgeons and policy makers should 
develop programs that will increase access to breast reconstruction in rural areas. 
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Appendices 
Appendix A: Tables 
 
Table 8. Demographic Frequencies for Individual Years in the United States 
 
2008 
 
2009 
 
2010 
 
Variable 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Age              
18-29 years old 327(1.4) 1029(0.6) 414(1.4) 938(0.5) 447(1.4) 1,184(0.7) 
30-39 years old 2,415(10.4) 8,139(4.5) 2,941(10.1) 7,124(4.1) 3,290(10.4) 6,874(4.0) 
40-49 years old 7,831(33.8) 27,149(14.9) 9,794(33.5) 24,003(13.7) 10,606(33.6) 24,714(14.2) 
50-59 years old 7,261(31.4) 40,132(22) 9,300(31.8) 38,214(21.8) 10,076(31.9) 38,429(22.1) 
60-69 years old 4,118(17.8) 43,738(23.9) 5,503(18.8) 43,388(24.8) 5,675(18) 43,872(25.2) 
70-79 years old 1,125(4.9) 36,509(20) 1,140(3.9) 36,264(20.7) 1,360(4.3) 34,983(20.1) 
80-90 years old 78(0.3) 26,009(14.2) 110(0.4) 25,332(14.5) 139(0.4) 23,758(13.7) 
Race        
White 15,118(79.5) 107,069(72.7) 19,469(76.1) 104,770(69.6) 22,70(77.3) 106,406(68.6) 
African American 1,475(7.8) 20,703(14.1) 2,237(8.7) 23,557(15.6) 2,929(10) 27,723(17.9) 
Hispanic 1,094(5.8) 11,088(7.5) 1,957(7.7) 12,531(8.3) 2,141(7.3) 13,036(8.4) 
Asian/Pacific 698(3.7) 4,251(2.9) 899(3.5) 4,170(2.8) 814(2.8) 3,673(2.4) 
Native American 49(0.3) 553(0.4) 222(0.9) 749(0.5) 56(0.2) 685(0.4) 
Other 583(3.1) 3,592(2.4) 794(3.1) 4,769(3.2) 732(2.5) 3,672(2.4) 
Payer type       
Private Insurance 18,384(79.5) 68,339(37.4) 22,892(78.5) 59,796(34.2) 24,452(77.5) 59,284(34.2) 
Self-pay 247(1.1) 3,047(1.7) 327(1.1) 3,906(2.2) 238(0.8) 3,623(2.1) 
Medicaid 1,074(4.6) 19,244(10.5) 1,707(5.9) 21,590(12.3) 2,281(7.2) 24,383(14.1) 
Medicare 2,928(12.7) 85,937(47.1) 3,355(11.5) 85,760(49) 3,920(12.4) 81,943(47.2) 
No charge 54(0.2) 1,112(0.6) 50(0.2) 556(0.3) 66(0.2) 915(0.5) 
Other 437(1.9) 4,828(2.6) 833(2.9) 3423(2.0) 610(1.9) 3,314(1.9) 
Household income 
status  
      
Low income 2,722(12) 46,387(25.8) 3,726(13.1) 46,406(27.3) 4,296(13.9) 47,655(28.1) 
Low/middle income 4,379(19.3) 47,559(26.5) 5,103(17.9) 44,793(26.4) 5,522(17.9) 40,966(24.2) 
High/middle 
income 
5,686(25) 42,209(23.5) 7,273(25.6) 39,598(23.3) 7,719(25) 41,564(24.5) 
High income 9,936(43.7) 43,341(24.1) 12,347(43.4) 39,191(23.1) 13,372(43.3) 39,374(23.2) 
Hospital 
location/teaching 
status  
      
Rural 443(1.9) 21,804(12) 702(2.5) 21,034(12.2) 680(2.2) 20,509(11.9) 
Urban nonteaching 7,616(32.9) 73,644(40.4) 9834(34.4) 73,067(42.5) 9,568(30.7) 68,217(39.6) 
Urban teaching 15,089(65.2) 87,003(47.7) 18,025(63.1) 77,704(45.2) 20,933(67.1) 83,417(48.5) 
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Table 8 cont. Demographic Frequencies for Individual Years in the United States 
  
2011 
 
2012 
 
2013 
  
Variable 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Reconstruction 
n(%) 
No 
reconstruction 
n(%) 
Age              
18-29 years old 444(1.3) 981(0.5) 385(1.2) 795(0.5) 375(1.2) 820(0.5) 
30-39 years old 3,141(9.3) 7,252(4.0) 3370(10.5) 6,805(4.1) 3,000(10.0) 6,060(3.8) 
40-49 years old 11,087(32.9) 23,637(13.1) 10,310(32.1) 20,815(12.6) 9,290(30.8) 19,395(12.2) 
50-59 years old 10,661(31.6) 38,657(21.5) 10,255(31.9) 35,810(21.6) 9,860(32.7) 34,950(22.0) 
60-69 years old 6,782(20.1) 47,101(26.2) 6,235(19.7) 43,255(26.1) 6,020(20.0) 41,495(26.1) 
70-79 years old 1,481(4.4) 37,045(20.6) 1,395(4.3) 32,860(19.9) 1,480(4.9) 32,605(20.5) 
80-90 years old 118(0.3) 25,443(14.1) 110(0.3) 25,180(15.2) 90(0.3) 23,550(14.8) 
Race        
White 23,716(75.4) 113,167(68.5) 22,475(73.2) 107,960(68.8) 20,725(72.6) 103,045(68.3) 
African American 3,253(10.3) 29,549(17.9) 3,275(10.7) 25,660(16.3) 3,095(10.8) 25,850(17.1) 
Hispanic 2,482(7.9) 13,571(8.2) 2,185(7.1) 12,880(8.2) 2,340(8.4) 12,705(8.4) 
Asian/Pacific 994(3.2) 4,157(2.5) 970(3.2) 4,485(2.9) 1,255(4.4) 4,710(3.1) 
Native American 56(0.2) 665(0.4) 105(0.3) 885(0.6) 65(0.2) 665(0.4) 
Other 962(3.1) 4,044(2.4) 1,675(5.5) 5,130(3.3) 1,010(3.5) 3,830(2.5) 
Payer type       
Private Insurance 25,845(76.7) 60,134(33.5) 24,140(75.2) 52,675(31.9) 22,205(73.8) 49,070(30.9) 
Self-pay 221(0.7) 2,902(1.6) 390(1.2) 3,235(2.0) 265(0.9) 3,155(2.0) 
Medicaid 2,230(6.6) 22,408(12.5) 2,655(8.3) 21,225(12.8) 2,725(9.1) 20,785(13.1) 
Medicare 4,538(13.5) 89,671(49.9) 4,185(13.0) 84,160(50.9) 3,950(13.1) 81,955(51.7) 
No charge 57(0.2) 479(0.3) 55(0.2) 420(0.3) 65(0.2) 535(0.3) 
Other 793(2.4) 4,097(2.3) 680(2.1) 3,505(2.1) 885(2.9) 3,160(2.0) 
Household income 
status  
      
Low income 4,586(13.8) 48,110(27.2) 4,490(14.2) 44,875(27.7) 4,025(13.6) 41,085(26.4) 
Low/middle income 5,780(17.4) 41,890(23.7) 5,680(18.0) 38,730(23.9) 5,595(18.9) 40,340(26.0) 
High/middle 
income 
9,081(27.4) 46,065(26.0) 8,545(27.0) 39,390(24.3) 7,920(26.8) 38,775(24.9) 
High income 13,690(41.3) 40,955(23.1) 12,900(40.8) 39,090(24.1) 12,060(40.7) 35,215(22.7) 
Hospital 
location/teaching 
status  
      
Rural 584(1.7) 20,246(11.4) 635(2.0) 17,520(10.6) 550(1.8) 16,920(10.6) 
Urban nonteaching 11,506(34.4) 70,466(39.5) 9360(29.1) 61,205(37.0) 8,740(29.0) 57,220(36.0) 
Urban teaching 21,402(63.9) 87,464(49.1) 22,155(68.9) 86,795(52.4) 20,825(69.2) 84,735(53.3) 
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Table 9. Complex Samples Logistic Regression Models for Independent Variables in the 
United States 
  2008    2009    2010    
Variable (reference 
group) 
OR C.I 
P-
value 
OR C.I 
P-
value 
OR C.I 
P-
value 
Age (40-49 years old)     <0.001     <0.001     <0.001 
18-29 years old 0.91 0.69-1.20  0.92 0.71-1.20  1.14 0.89-1.46  
30-39 years old 0.97 0.87-1.09  0.99 0.89-1.10  0.90 0.81-1.00  
50-59 years old 1.60 1.47-1.72  1.68 1.56-1.80  1.64 1.52-1.76  
60-69 years old  3.07 2.80-3.36  3.22 2.96-3.49  3.32 3.06-3.60  
70-79 years old 9.37 8.12-10.80  13.0 11.2-15.0  11.0 9.68-12.6  
80-90 years old 96.3 58.7-158  93.7 61.8-142  73.6 50.2-108  
Race (African 
American) 
  <0.001   <0.001   <0.001 
White 0.51 0.45-0.57  0.51 0.46-0.57  0.50 0.45-0.54  
Hispanic 0.72 0.60-0.86  0.61 0.53-0.70  0.64 0.56-0.74  
Asian/Pacific 0.43 0.35-0.54  0.44 0.37-0.53  0.48 0.39-0.58  
Native American 0.80 0.41-1.55  0.32 0.22-0.46  1.29 0.69-2.41  
Other 0.44 0.35-0.55  0.57 0.47-0.69  0.53 0.44-0.65  
Payer type (private 
insurance) 
  <0.001   <0.001   <0.001 
Self-pay 3.32 2.48-4.44  1.57 1.32-1.88 
 6.27 4.66-8.42  
Medicaid 4.82 4.19-5.54  4.23 2.05-8.72  4.41 3.98-4.88  
Medicare 7.89 7.22-8.63  9.79 8.99-10.7  8.62 7.96-9.34  
No charge 5.57 3.04-10.2  4.84 4.31-5.44  5.72 3.25-10.1  
Other 2.97 2.39-3.69  4.57 3.53-5.92  2.24 1.84-2.73  
Household income 
status (high income) 
  <0.001   <0.001   <0.001 
Low income 3.91 3.54-4.31  3.92 3.59-4.28  3.77 3.47-4.09  
Low/middle income 2.49 2.29-2.71  2.77 2.56-2.99  2.52 2.33-2.72  
High/middle income 1.70 1.57-1.84  1.72 1.60-1.84  1.83 1.70-1.96  
Hospital 
location/teaching 
status 
(urban/teaching) 
  <0.001   <0.001   <0.001 
Rural 8.53 6.87-10.6  6.95 5.86-8.25  7.57 6.42-8.93  
Urban nonteaching 1.68 1.57-1.79  1.72 1.62-1.83  1.79 1.69-1.90  
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Table 9 cont. Complex Samples Logistic Regression Models for Independent Variables in 
the United States 
  
201
1 
 
  
2012 
    
2013 
    
Overall NIS database 
Variable 
(reference 
group) 
OR C.I 
P-
value 
OR C.I 
P-
value 
OR C.I 
P-
value 
OR C.I 
P-
value 
Age (40-49 
years old)   
<0.001 
  
<0.001 
  
<0.001 
  
<0.001 
18-29 years 
old 
1.04 
0.81-
1.33 
 1.02 
0.78-
1.35 
 1.05 
0.79-
1.38 
 1.01 
0.91-
1.13 
 
30-39 years 
old 
1.08 
0.98-
1.20 
 1.00 
0.90-
1.11 
 0.97 
0.87-
1.08 
 0.98 
0.94-
1.03 
 
50-59 years 
old 
1.70 
1.59-
1.82 
 1.73 
1.61-
1.86 
 1.70 
1.58-
1.83 
 1.66 
1.61-
1.71 
 
60-69 years 
old  
3.26 
3.02-
3.51 
 3.39 
3.13-
3.67 
 3.30 
3.04-
3.58 
 3.22 
3.12-
3.33 
 
70-79 years 
old 
11.7 
10.4-
13.3 
 11.7 
10.2-
13.3 
 10.6 
9.28-
12.0 
 11.1 
10.5-
11.7 
 
80-90 years 
old 
101 67.9-151  113 
74.3-
173 
 125 
78.6-
200 
 97.7 
82.1-
116 
 
Race (African 
American) 
  <0.001   <0.001   <0.001   <0.001 
White 0.53 
0.48-
0.57 
 0.61 
0.56-
0.67 
 0.60 
0.54-
0.65 
 0.55 
0.53-
0.57 
 
Hispanic 0.60 
0.53-
0.68 
 0.75 
0.66-
0.86 
 0.63 
0.56-
0.72 
 0.66 
0.62-
0.70 
 
Asian/Pacific 0.46 
0.39-
0.55 
 0.59 
0.50-
0.70 
 0.45 
0.38-
0.53 
 0.48 
0.45-
0.52 
 
Native 
American 
1.30 
0.71-
2.37 
 1.08 
0.68-
1.70 
 1.23 
0.69-
2.18 
 0.81 
0.66-
0.99 
 
Other 0.46 
0.39-
0.55 
 0.39 
0.34-
0.45 
 0.45 
0.38-
0.54 
 0.46 
0.43-
0.50 
 
Payer type 
(private 
insurance) 
  <0.001   <0.001   <0.001   <0.001 
Self-pay 5.63 
4.17-
7.60  
3.80 
3.00-
4.82 
 5.39 
4.06-
7.15 
 4.65 
4.15-
5.19 
 
Medicaid 4.32 
3.90-
4.78 
 3.66 
3.33-
4.04 
 3.45 
3.14-
3.80 
 4.04 
3.87-
4.22 
 
Medicare 8.49 
7.90-
9.13 
 9.22 
8.53-
9.96 
 9.39 
8.67-
10.2 
 8.79 
8.51-
9.08 
 
No charge 3.62 
1.98-
6.59 
 3.50 
1.87-
6.57 
 3.73 
2.09-
6.63 
 4.57 
3.56-
5.87 
 
Other 2.22 
1.88-
2.63 
 2.36 
1.96-
2.85 
 1.62 
1.36-
1.92 
 2.08 
1.93-
2.24 
 
Household 
income status 
(high income) 
  <0.001   <0.001   <0.001   <0.001 
Low income 3.51 
3.24-
3.80 
 3.30 
3.04-
3.58 
 3.50 
3.21-
3.81 
 3.61 
3.48-
3.74 
 
Low/middle 
income 
2.42 
2.25-
2.61 
 2.25 
2.08-
2.43 
 2.47 
2.29-
2.67 
 2.49 
2.41-
2.57 
 
High/middle 
income 
1.70 
1.59-
1.81 
 1.52 
1.42-
1.63 
 1.68 
1.56-
1.80 
 1.68 
1.63-
1.73 
 
Hospital 
location/teach
ing status 
(urban/teachi
ng) 
  <0.001   <0.001   <0.001   <0.001 
Rural 8.48 
1.01-
10.3 
 7.04 
5.88-
8.43 
 7.56 
6.23-
9.17 
 7.67 
7.11-
8.27 
 
Urban 
nonteaching 
1.50 
1.42-
1.58 
 1.67 
1.57-
1.77 
 1.61 
1.51-
1.74 
 1.67 
1.63-
1.71 
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Table 10. Complex Samples Multiple Logistic Regression for Individual Years in the 
United States 
  2008    2009    2010    
Variable (reference 
group) 
OR C.I 
P-
value 
OR C.I 
P-
value 
OR C.I 
P-
value 
Age (40-49 years old)   <0.001   <0.001   <0.001 
18-29 years old 0.73 0.53-1.01  0.87 0.62-1.22  1.16 0.85-1.57  
30-39 years old 0.98 0.85-1.12  1.02 0.90-1.17  1.01 0.89-1.14  
50-59 years old 1.27 1.15-1.40  1.35 1.23-1.48  1.36 1.24-1.48  
60-69 years old  1.68 1.50-1.89  1.72 1.55-1.91  1.94 1.76-2.15  
70-79 years old 3.28 2.70-3.97  4.61 3.85-5.51  4.23 3.59-4.99  
80-90 years old 31.8 18.0-55.8  26.6 17.15-41.1  27.1 17.6-41.5  
Race (African 
American) 
  <0.001   <0.001   <0.001 
White 0.69 0.52-0.93  0.45 0.33-0.60  0.48 0.38-0.62  
Hispanic 0.91 0.60-1.37  0.39 0.26-0.57  0.67 0.49-0.94  
Asian/Pacific 1.03 0.68-1.55  0.55 0.37-0.82  1.02 0.69-1.51  
Native American 0.36 0.094-1.39  0.27 0.10-0.74  N/A N/A  
Other 1.14 0.70-1.88  0.52 0.33-0.82  0.59 0.38-0.93  
Payer type (private 
insurance) 
  <0.001   <0.001   <0.001 
Self-pay 2.70 1.90-3.82  4.70 3.38-6.53 
 1.80 1.43-2.27  
Medicaid 3.2 2.71-3.78  3.9 3.38-4.51  6.43 3.53-11.7  
Medicare 1.83 1.61-2.08  2.18 1.94-2.45  1.88 1.69-2.09  
No charge 6.53 3.25-13.1  3.51 1.60-7.72  3.71 3.26-4.21  
Other 2.16 1.66-2.82  1.37 1.10-1.71  5.38 3.84-7.54  
Household income 
status (high income) 
  <0.001   <0.001   <0.001 
Low income 2.33 1.64-3.30  1.40 1.01-1.95  1.75 1.33-2.31  
Low/middle income 1.83 1.26-2.66  1.20 0.84-1.72  1.40 1.02-1.92  
High/middle income 1.45 1.00-2.12  0.72 0.51-1.01  1.33 0.99-1.80  
Hospital 
location/teaching 
status 
(urban/teaching) 
  <0.001   <0.001   <0.001 
Rural 3.02 1.18-7.70  7.56 1.78-32.15  12.1 3.79-38.4  
Urban nonteaching 1.28 0.96-1.69  1.41 1.11-1.81  1.25 0.99-1.57  
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Table 10 cont. Complex Samples Multiple Logistic Regression for Individual Years in the 
United States 
  2011     2012     2013     
Variable (reference 
group) 
OR C.I 
P-
value 
OR C.I 
P-
value 
OR C.I 
P-
value 
Age (40-49 years old) 
  
<0.001 
  
<0.001 
  
<0.001 
18-29 years old 1.08 
0.81-
1.45 
 1.00 0.73-1.37  1.21 0.88-1.66  
30-39 years old 1.18 
1.05-
1.34 
 1.12 0.99-1.27  1.11 0.97-1.26  
50-59 years old 1.35 
1.25-
1.47 
 1.40 1.29-1.53  1.32 1.21-1.45  
60-69 years old  1.83 
1.66-
2.01 
 1.81 1.64-2.00  1.68 1.52-1.87  
70-79 years old 4.62 
3.95-
5.42 
 4.05 3.44-4.77  3.00 2.55-3.55  
80-90 years old 38.7 
24.7-
60.7 
 31.9 20.5-49.7  34.6 20.9-57.2  
Race (African 
American) 
  0.02   <0.001   <0.001 
White 0.78 
0.63-
0.96 
 0.55 0.43-0.70  0.83 0.65-1.05  
Hispanic 0.93 
0.68-
1.28 
 0.73 0.52-1.04  1.04 0.74-1.47  
Asian/Pacific 1.1 
0.77-
1.57 
 1.38 0.97-1.98  1.36 0.97-1.89  
Native American 1.4 
0.30-
6.46 
 1.64 0.58-4.61  6.84 0.83-56.1  
Other 0.75 
0.51-
1.11 
 0.52 0.37-0.73  0.91 0.62-1.34  
Payer type (private 
insurance) 
  <0.001   <0.001    
Self-pay 7.54 
5.08-
11.2  
3.61 2.77-4.71  4.59 3.37-6.24  
Medicaid 3.01 
2.67-
3.38 
 2.81 2.52-3.14  2.56 2.29-2.87  
Medicare 1.83 
1.65-
2.02 
 2.04 1.84-2.26  2.19 1.97-2.44  
No charge 2.93 
1.53-
5.64 
 3.27 1.71-6.24  3.63 1.97-6.68  
Other 1.67 
1.37-
2.04 
 1.82 1.47-2.24  1.37 1.11-1.69  
Household income 
status (high income) 
  <0.001   0.10   <0.001 
Low income 2.39 
1.86-
3.08 
 1.38 1.05-1.82  1.91 1.46-2.51  
Low/middle income 1.47 
1.12-
1.95 
 1.27 0.94-1.71  1.75 1.30-2.35  
High/middle income 1.38 
1.06-
1.79 
 0.94 0.70-1.26  1.48 1.10-1.99  
Hospital 
location/teaching 
status 
(urban/teaching) 
  <0.001   <0.001   <0.001 
Rural 10.22 
3.12-
33.53 
 7.85 2.55-24.2  27.7 4.13-186  
Urban nonteaching 1.52 
1.24-
1.87 
 1.29 1.04-1.59  1.65 1.31-2.07  
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Table 16. Individual Independent Variables Logistic Regression for Nevada 
Variable (reference group) OR C.I P-value 
Age (41-64 years old)   <0.001 
18-40 years old 0.47 0.37-0.60  
65-90 years old 3.30 2.70-4.03  
Race (nonwhite)   <0.001 
White 1.45 1.20-1.75  
Payer type (private insurance)   <0.001 
Self-pay 6.49 3.05-13.9  
Medicaid 4.98 3.27-7.58  
Medicare 5.13 4.18-6.29  
Other 2.65 1.56-4.52  
Household income status (high 
income) 
  <0.001 
Low income 2.14 1.62-2.84  
Low/middle income 1.54 1.23-1.92  
High/middle income 1.13 0.94-1.36  
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Appendix B: Healthcare Cost and Utilization Project Certification 
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Appendix C: Internal Review Board Exclusion  
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